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A B S T R A C T
Photoaging and epithelial skin tumorigenesis are complex processes triggered mainly by UV radiation from
chronic sun exposure. This leads to DNA damage and reactive oxygen species (ROS) production, which initiate
an inﬂammatory response that alters cell structure and function.
Changes in cell homeostasis and ROS production activate intracellular multiprotein platforms called in-
ﬂammasomes. Inﬂammasomes nucleate around cytoplasmic receptors mainly of the NLR (nucleotide-binding
domain and leucine-rich repeat) family and regulate caspase-1-dependant secretion of pro-inﬂammatory inter-
leukin (IL)1β and IL18 cytokines, and an inﬂammatory form of death named pyroptosis.
NLRP1 inﬂammasomes have taken centre stage in skin biology, as mutations in NLRP1 underlie the genetic
etiology of dermatological diseases and increase the susceptibility to skin cancer. Targeting inﬂammasome(s)
might be an important approach to improve skin inﬂammation, photoaging and reduce the risk of epithelial skin
tumorigenesis. In this context, we discuss the potential implication of NLRP1 and NLRP3 inﬂammasomes.
1. Introduction
Human skin which is the largest organ in the body, it interacts with
the environment, protects from mechanical pressure and radiation and
plays an important role in defense against invading pathogens. Like
other organs, human skin undergoes intrinsic (chronological) aging as
well as extrinsic aging (photoaging) mainly due to the eﬀect of ultra-
violet (UV) radiation (UVR), from chronic sun exposure (Fisher et al.,
2002). UV radiation (which comprises UVA and UVB) leads to DNA
damage and production of reactive oxygen species (ROS), both of which
promote inﬂammation and tumorigenesis (Calleja-Agius et al., 2013;
Pillai et al., 2005; Yaar and Gilchrest, 2007; Bachelor and Bowden,
2004; Hussain et al., 2003). Interestingly, ROS, damaged DNA and al-
tered cell homeostasis are also activators of intracellular protein plat-
forms known as inﬂammasomes (Martinon, 2012). Following stimula-
tion, keratinocytes the major cell type present in the skin, and to a
lesser extent melanocytes and Langerhans cells, secrete pro-in-
ﬂammatory cytokines (Feldmeyer et al., 2007; Sollberger et al., 2015;
Mantovani et al., 2008), which regulate innate and adaptive immune
responses (Nasti and Timares, 2012; Ortiz et al., 2015). Cytokines and
growth factors through paracrine and autocrine actions deﬁne a local
microenvironment capable of either supporting or limiting inﬂamma-
tion and tumor growth (de Visser et al., 2006; Lin and Karin, 2007;
Smyth et al., 2006). Persistent chronic inﬂammation and altered in-
ﬂammasome activity have been recently implicated in inﬂammatory
skin disorders including cancer (Feldmeyer et al., 2007; Sollberger
et al., 2015; Zhong et al., 2016; Grandemange et al., 2017; Elinav et al.,
2013; Grivennikov et al., 2010; Tang and Wang, 2016). This mini re-
view aims to discuss the role of inﬂammasome in skin inﬂammation
linked with photoaging and skin cancer, in humans.
2. NLRs and inﬂammasomes
Immune cells express a number of membrane-bound and in-
tracellular pattern recognition receptors in order to detect homeostatic
changes that can lead to disease. Intracellular proteins which can nu-
cleate inﬂammasomes belong to the family of Nucleotide-binding do-
main and Leucine-rich Repeat containing receptors, (NLRs), the PYHIN
family (PYD and HIN domain containing proteins) or the tripartite
motif family (TRIM) (Fig. 1). In this review we will focus on the NLRs
due to their recent implication in skin pathologies. NLRs are multi-
domain proteins (Ting et al., 2008), subdivided into subgroups based on
their N-terminal eﬀector domain. Among the N-terminal domains im-
portant for downstream interactions can be a pyrin (PYD), or a caspase
activation and recruitment domain (CARD) (Fig. 1). All NLRs also
contain a central NACHT nucleotide-binding domain, (also known as
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NOD), required for ATP-dependent self-oligomerization and a C-term-
inal leucine-rich repeat (LRR) domain. NLRs sense infection and/or
stress through the recognition of cytoplasmic pathogen-associated
molecular patterns (PAMPs), damage-associated molecular patterns
(DAMPs) (Martinon, 2008) or, as the more recently deﬁned, home-
ostasis-altering molecular processes (HAMPs) (Liston and Masters,
2017). Detection of a DAMP or a PAMP by the LRR domain activates the
NLR, leading to the formation of the inﬂammasome, a multiprotein
signaling platform. Inﬂammasomes are generally assembled through
homotypic interactions between the N-terminal PYD domain of the NLR
and the PYD domain of the adaptor protein ASC (Apoptosis-associated
Speck-like protein containing a CARD), which then recruits pro-cas-
pase-1 through CARD–CARD domain interactions. This leads to for-
mation of an active caspase-1 heterodimer (Martinon and Tschopp,
2004), which then proteolytically processes the pro-forms of (inter-
leukin 1β) IL1β and (interleukin 18) IL18 pro-inﬂammatory cytokines,
leading to their maturation and secretion.
The presence of caspase-1 is central to what is known as “canonical
inﬂammasome”; however, today pro-inﬂammatory caspases −4 and
−5 have also been demonstrated in non-canonical (caspase-1–in-
dependent) inﬂammasomes, which do not require a cytoplasmic re-
ceptor like NLR for the pathogen detection. Both caspase−4 and 5 can
directly bind LPS in vitro (Shi et al., 2014) and, in human macrophages,
caspase-4 is critical for non-canonical inﬂammasome responses against
virulent gram-negative bacteria (Casson et al., 2015). The diﬀerent
tissue expression proﬁle between caspase-4 and caspase-5 (Lin et al.,
2000), suggests that they may have cell/tissue-speciﬁc roles. The fact
that LPS can be directly detected by caspase−4/-5 in the cytoplasm of
non-myeloid cells (Shi et al., 2014) and the broad expression of these
caspases in non-immune cells suggested that this might be a protective
mechanism of pathogen detection from non-immune cells. Apart from
cytokine secretion, activation of inﬂammasomes results in pyroptosis,
an inﬂammatory cell death due to the formation of pores in the plasma
membrane and consequent release of the cytosolic content into the
extracellular space (Aachoui et al., 2013). The mechanism of pyroptosis
was recently clariﬁed by the identiﬁcation of gasdermin D which can be
cleaved by caspases-1,−4 or−5 (Shi et al., 2015). Following cleavage,
the N-terminal domain of gasdermin D associates with cell membrane
and oligomerizes creating pores. Pyroptosis is speciﬁc to caspase-1,
caspase-4 and caspase-5 activation, and is considered a way of cell
death, which promotes clearance of intracellular microbes and infected
cells, exposing pathogens to extracellular defenses (Miao et al., 2011).
More than 22 NLRs are known in humans and although the major
attributed roles are linked to immunity (Harton et al., 2002), several
NLRs also play important roles during embryonic development and
reproduction (Kufer and Sansonetti, 2011; Lupfer and Kanneganti,
2013; Murdoch et al., 2006). Under physiological conditions,
inﬂammasomes mainly regulate host defense and pathogen clearance
through pro-inﬂammatory signaling. However, a dysregulated in-
ﬂammasome activity leads to disease (Strowig et al., 2012). The best
illustration of this, are the hereditary auto-inﬂammatory syndromes
caused by mutations in NLRP3, encoding for the protein NLRP3/cryo-
pyrin, which lead to a constitutively active inﬂammasome, and in-
creased levels of IL1β in patients’ cells are the hallmark of the disease.
Interestingly, in these auto-inﬂammatory syndromes named CAPS
(cryopyrin associated periodic syndromes), the majority of the patients,
in addition to fever and serosal inﬂammation, also present with in-
ﬂammatory skin lesions (Hoﬀman et al., 2001; Aksentijevich et al.,
2002). Inﬂammasome activity has been implicated in the pathophy-
siology of a number of inﬂammatory and metabolic diseases (Strowig
et al., 2012). In addition, sequence variants in several NLRs are asso-
ciated with multifactorial polygenic human diseases, such as poly-
morphisms in NOD2 predispose to the development of Crohn’s disease
(Abraham and Cho, 2006; Rehaume et al., 2010; Paramel et al., 2015).
Genome-wide association studies (GWAS) have identiﬁed risk alleles in
NLR genes in a number of diseases including multiple sclerosis, multi-
bacillary leprosy and vitiligo (reviewed in (Zhong et al., 2013).
3. Biology of NLRP1 and NLRP3 inﬂammasomes
NLRP1 inﬂammasome was the ﬁrst to be described in “im-
munoprecipitated” THP1 cell extracts. The complex contained NLRP1,
caspase-1, caspase-5 and the adaptor protein ASC (Martinon et al.,
2002). Unlike other NLRs, NLRP1 contains a N-terminal PYD domain
whereas at the C-terminal it contains a FIIND (“function to ﬁnd do-
main”) and a CARD domain (Chu et al., 2001). Experiments using ba-
culovirus-expressed recombinant proteins, to reconstitute the NALP1
inﬂammasome showed that the CARD domain of NLRP1 directly in-
teracts with the CARD domain of pro-caspase-1 without a requirement
for the presence of the adaptor protein ASC (Faustin et al., 2007). The
presence of ASC intensiﬁed pro-caspase activation (Faustin et al.,
2007). However, in a cell-based system Finger et al. (2012), demon-
strated that human NLRP1 activity is ASC-dependent. The authors
proposed that NLRP1 inﬂammasome formation requires ASC dimers.
The dimers are formed through interactions of the ASC-PYD domains.
Through their CARD domains ASC dimers interact with the C-terminal
CARD domain of NLRP1 and the CARD domain of pro-caspase-1,
forming the inﬂammasome (Fig. 2). These results were later conﬁrmed
by Zhong et al. (2016). Furthermore the authors showed that human
NLRP1 activity depends on autolytic proteolysis between amino acids
Phe1212 and Ser1213 within the (FIIND) domain (Finger et al., 2012).
Single nucleotide polymorphisms or alternative mRNA splicing near the
cleavage site, impact profoundly NLRP1 processing and inﬂammasome
activity (Finger et al., 2012; D’Osualdo et al., 2011). Importantly, this
Fig. 1. Schematic representation of the human in-
ﬂammasome-forming proteins. The (so far) known
cytoplasmic receptors forming inﬂammasomes are:
NLRP1, NLRP3, NLRC4, Pyrin and AIM2. NLRP1,
NLRP3, NLRC4 belong to Nucleotide-binding domain
and Leucine-rich Repeat receptors (NLR). NLRs con-
tain a central NACHT domain which mediates ATP-
dependent self-oligomerization, common to all NLRs,
in addition to a C-terminal leucine-rich repeat (LRR)
and variable N-terminal interaction domain. The N-
terminal domain is responsible for homotypic pro-
tein–protein interactions and it can be a pyrin do-
main (PYD) as in NLRP3, or a caspase recruitment
domain (CARD) as in NLRC4. NLRP1 is unique
among the NLR family as it is characterized by a N-
terminal PYD domain and a C-terminal CARD do-
main in addition to a FIIND (“function to ﬁnd do-
main”). Pyrin is part of the protein family termed
TRIpartite Motif (TRIM), which contains, a B-box, a
coiled-coil (CC), and a B30.2 domain. TRIM proteins are antiviral proteins involved in innate immunity. AIM2 (which belongs to the PYHIN family) contains a PYD domain and a DNA-
binding HIN domain.
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post-translational event depends on the highly conserved His1186.
Following autoproteolysis the cleavage product remains associated with
the rest of the molecule through non-covalent binding (Finger et al.,
2012; Chavarría-Smith et al., 2016). The contribution of the PYD do-
main in NLRP1 inﬂammasome activation was recently clariﬁed as it
was shown that it keeps NLRP1 in an inhibitory state (Zhong et al.,
2016). Mutations in the PYD-NLRP1 domain were associated with a
constitutive NLRP1 self-oligomerization and inﬂammasome activation
(Zhong et al., 2016) (Fig. 2). Furthermore, proteolysis within a speciﬁc
N-terminal linker region removing the PYD domain was suﬃcient to
activate human NLRP1 (Chavarría-Smith et al., 2016). Zhong et al.
suggested that the diﬀerent function of NLRP1-PYD as compared to the
other PYD-containing proteins may be linked to structural diﬀerences.
Indeed the NLRP1-PYD forms a bundle of ﬁve α helices (Hiller et al.,
1993), as compared to the six helices formed by the canonical death
domain fold superfamily. Sequence comparison of all PYDs encoded in
the human genome revealed that NLRP1 PYD deﬁnes its own group
(Zhong et al., 2016). Mutations in the LRR domain showed similar re-
sults to those of the PYD domain (both leading to NLRP1 autoactiva-
tion) (Fig. 2) also suggesting a potential inhibitory role of LRR on
NLRP1 (Zhong et al., 2016; Grandemange et al., 2017).
Interestingly, NLRP1 is not conserved across species. In mice, Nlrp1
exist in three paralogs; Nlrp1a, Nlrp1b and Nlrp1c all of which are
devoid of the N-terminal PYD domain present in the human protein
(Boyden and Dietrich, 2006). The presence of Bacillus anthracis lethal
toxin in the cytoplasm of mouse cells speciﬁcally activates Nlrp1
(Boyden and Dietrich, 2006; Hsu et al., 2008) as does muramyl di-
peptide, a bacterial cell wall fragment (Faustin et al., 2007), which is
also an activator of NOD2. Recent studies showed that neither lethal
toxin nor muramyl dipeptide can activate human NLRP1 (Yu et al.,
2018). Toxoplasma gondii was shown to activate human NLRP1 in-
ﬂammasome in monocytic cells (Witola et al., 2011). The molecular
basis of the interaction between the ligand and NLRP1 remains incon-
clusive.
NLRP3 is the best characterized inﬂammasome. NLRP3 has an N-
terminal PYD domain necessary for the interaction with ASC (Yu et al.,
2006), a central NACHT domain required for auto-oligomerization and
a C-terminal LRR region probably involved in the recognition of dif-
ferent pathogen and danger signals (Figs. 1 and 3). NLRP3 is primarily
expressed in cells of the myelomonocytic lineage (Manji et al., 2002;
Feldmann et al., 2002) and is induced upon exposure to inﬂammatory
stimuli (O’Connor et al., 2003; Awad et al., 2017). NLRP3 is also ex-
pressed in keratinized epithelial cells although weakly (Kummer et al.,
2007), a ﬁnding that could explain the urticaria-like rash in CAPS pa-
tients.
NLRP3 inﬂammasome formation is regulated both at the tran-
scriptional and posttranslational level. A priming step usually involves
LPS signaling through Tolllike Receptor resulting in the activation of
NF-κB and transcription of NLRP3 and IL1B. Posttranslational mod-
iﬁcations of NLRP3 have also been described as priming step (Juliana
et al., 2012). The second step triggers assembly of the NLRP3 in-
ﬂammasome complex and can be of a variable nature, a DAMP, a
PAMP, or a HAMP (Tschopp and Schroder, 2010; Kingsbury et al.,
2011; Guo et al., 2015; Liston and Masters, 2017) (Fig. 3). NLRP3 in-
ﬂammasome is activated by several microbial patterns like the bacterial
toxin nigericin and LPS, by environmental irritants and nanoparticles
and by cellular damage molecules like ATP, glucose (Schroder and
Tschopp, 2010), cholesterol crystals (Duewell et al., 2010), or even
virus and parasites (Ichinohe et al., 2010; Thomas et al., 2009; Zamboni
and Lima-Junior, 2015; Franchi et al., 2012). Many of these activators
are involved in the pathogenesis of common metabolic inﬂammatory
and infectious diseases making NLRP3 inﬂammasome one of the most
studied in human pathophysiology (Guo et al., 2015). Due to the highly
variable structures of all these molecular patterns, a unifying molecular
mechanism, linking them to NLRP3 inﬂammasome activation is still
missing. The prevailing model suggests that NLRP3 senses molecular
patterns indirectly and cellular stress signals are proposed as potential
intermediate steps in NLRP3 inﬂammasome activation (Latz, 2010).
Alterations in ion homeostasis, mainly in cytosolic K+ eﬄux (Pétrilli
et al., 2007) or Ca2+ mobilisation (Murakami et al., 2012) appear
among the plausible bridging mechanisms. Another mechanism ap-
plying to DAMPs which are phagocytized, is through lysosomal damage
Fig. 2. NLRP1 inﬂammasome activation. Under
resting conditions, the PYD domain of NLRP1 keeps
the protein in an auto-inhibited state through inter-
actions which are not yet well characterized.
Activation of human NLRP1 occurs by unknown –so
far- activators or through recently identiﬁed muta-
tions in PYD or LRR domains (indicated with a star
symbol). Active NLRP1 undergoes autolytic proteo-
lysis between Phe1212 and Ser1213 (F1212-S1213)
in the FIIND domain. The cleavage product remains
associated through non-covalent binding and inter-
acts with ASC through CARD–CARD domain inter-
actions. A second ASC molecule is recruited through
its PYD domain, which then recruits pro-caspase-1 to
the complex through CARD–CARD domain interac-
tions between ASC and pro-caspase 1. This leads to
caspase-1 activation followed by IL1β and IL18
proteolytic maturation and release of proin-
ﬂammatory cytokines by an unknown mechanism.
Caspase-1 activation induces also pyroptosis (an in-
ﬂammatory cell death) through the cleavage of
Gasdermin D, a membrane-pore-forming protein also
leading to release of proinﬂammatory cytokines and
other alarmins in the extracellular space.
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(Hornung and Latz, 2010) and release of lysosomal proteases such as
cathepsin-B, which then activate the NLRP3 inﬂammasome. An im-
portant role for mitochondria and reactive oxygen species has also been
reported in NLRP3 inﬂammasome activation (Tschopp and Schroder,
2010; Nakahira et al., 2011; Zhou et al., 2011; Shimada et al., 2012;
Subramanian et al., 2013).
Canonical inﬂammasome activation is characterized by caspase-1
cleavage, the maturation and release of IL1β and IL18 and the induction
of pyroptosis. The methods commonly used to study inﬂammasome
activation in response to a DAMP/PAMP in stimulated cells or tissue
homogenates include gene expression of inﬂammasome components,
protein expression of the inﬂammasome/NLR receptor, release of
cleaved caspase-1 by western blot, secretion of mature IL1β and IL18 by
western blot and ELISA and release of Lactate Dehydrogenase (LDH) to
identify pyroptosis. ASC specks which are oligomers of ASC, are visible
under the microscope, and are used to study inﬂammasome activation
for the inﬂammasomes requiring ASC (Beilharz et al., 2016; Fernandes-
Alnemri et al., 2007; Stutz et al., 2013). ASC specks can also be detected
extracellularly (Baroja-Mazo et al., 2014; Franklin et al., 2014).
4. NLRP1, NLRP3 inﬂammasomes in photoaging and skin
disorders including cancer
UVR leads to decomposition of sebaceous lipids and initiation of an
inﬂammatory process. Physiological doses of UVA oxidize squalene,
one of the major lipid components of sebum. When oxidized squalene
derivatives from human sebum were applied to cultured skin, they in-
duced inﬂammatory cytokine expression, that promoted downstream
inﬂammation (Kostyuk et al., 2012). As oxidized skin surface lipids
have a diagnostic value in the inﬂammatory skin disorders and pho-
toaging, their potential action as inﬂammasome activating danger sig-
nals merits further consideration (Oyewole and Birch-Machin, 2015; De
Luca and Valacchi, 2010).
Keratinocytes express several inﬂammasome related-genes sup-
porting the hypothesis that inﬂammasomes may have a role in skin
inﬂammation (Feldmeyer et al., 2007; Sollberger et al., 2015). UVB
exposure induces NLRP3 inﬂammasome activation and IL1β secretion
in HaCaT cells, an immortal keratinocyte cell line, through disturbances
in Ca2+ homeostasis (Ahmad et al., 2017). NLRP3 expression was
higher in human basal cell carcinoma tumor samples and this was ac-
companied by higher IL1β levels and caspase-1 activation as compared
to healthy skin (Ahmad et al., 2017). Caspase-4 is important for eﬃ-
cient UVB-induced activation of caspase-1 and in turn for IL1β and IL18
secretion in human keratinocytes (Sollberger et al., 2012). Pannexin-1
channels shown to be implicated in keratinocyte diﬀerentiation (Celetti
et al., 2010) and in ATP release from pyrinergic receptors which induce
inﬂammasome activation (Latz et al., 2013), are present in skin mela-
nocytes and are up-regulated during melanoma progression in mouse
melanoma cell lines (Penuela et al., 2012).
NLRP1 is strongly expressed in human skin as compared to other
NLRs (Zhong et al., 2016; Uhlén et al., 2015). Polymorphisms in coding
and non-coding regions of NLRP1 have also been associated with viti-
ligo, an autoimmune disease aﬀecting skin melanocytes, where patients
are reported to have elevated serum IL1β levels (Jin et al., 2007;
Levandowski et al., 2013). NLRP1 genetic variations have been shown
to induce susceptibility to psoriasis (Ekman et al., 2014) and corneal
intraepithelial dyskeratosis (Soler et al., 2013). In a recent work,
Grandemange et al. showed that mutations in NLRP1 are causal for a
new auto-inﬂammatory disease in which patients present with arthritis
and dyskeratosis, accompanied by high levels of serum caspase-1 and
IL18 (Grandemange et al., 2017).
As shown in a Swedish case–control study (Verma et al., 2012)
polymorphisms in NLRP1 and NLRP3 are associated with sporadic
malignant melanoma, one of the most severe skin cancers. Furthermore,
in a Brazilian case/control cohort of sporadic malignant melanoma,
selected polymorphisms in the inﬂammasome-related genes CARD8,
IL1B and IL18 have been shown to associate with melanoma suscept-
ibility and progression (Da Silva et al., 2016). In the same study, IL1 B
and CARD8 expression was increased in melanoma as compared to
benign nevus. Interestingly, IL18 was decreased, potentially suggesting
Fig. 3. NLRP3 inﬂammasome activation. NLRP3 in-
ﬂammasome activation requires two signals: A ﬁrst
signal (most commonly LPS) induces transcriptional
activation of NLRP3 and IL1B through TLR4 signaling.
Deubiquitination of NLRP3 is also possible during this
step. A second signal, a DAMP or a PAMP or a HAMP
leads to NLRP3 oligomerization (not shown). ASC
associates with NLRP3 through PYD domain interac-
tions which bring pro-caspase-1 in the complex
through CARD domain interactions. Activation of pro-
caspase-1 leads to active caspase-1 (p20-p10 dimers
which in solution associate in tetramers) which ma-
turates IL1β and IL18 leading to their release by a yet
unknown mechnism. Caspase-1 activation induces
also pyroptosis (an inﬂammatory cell death) through
the cleavage of Gasdermin D, a membrane-pore-
forming protein also leading to the release of proin-
ﬂammatory cytokines and alarmins in the extra-
cellular space. Due to the variety of the patterns
which can activate NLRP3, it is suggested that NLRP3
does not recognize them directly and cellular stress
signals are proposed as potential intermediate steps in
NLRP3 activation. Among the most prevailing are:
increase in potassium eﬄux, calcium mobilisation,
ROS production, mitochondrial dysfunction, lyso-
somal damage and cathepsin release.
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a protective role of this inﬂammasome-dependent cytokine in mela-
noma development and progression (Da Silva et al., 2016).
Using human melanoma cell lines established from diﬀerent disease
stages as well as human melanoma specimens, Okatomo et al. showed
that cells from late stage human melanoma secrete active IL1β spon-
taneously without a requirement of exogenous stimulation.
Intermediate stage melanoma cells require activation for active IL1β
secretion similar to cells from early stage melanoma (Okamoto et al.,
2010). The latter provided evidence that late stage human melanoma
cells show similar characteristics as cells from patients with auto-in-
ﬂammatory diseases (caused by gain-of-function mutations in NLRP3),
suggesting that the constitutive secretion of active IL1β and its down-
stream eﬀectors may be causal in the aggressiveness of this type of skin
cancer. These results also suggested a role for the inﬂammasome
component ASC in human melanoma. Several studies have shown an
implication of ASC in cancers, through ASC methylation and silencing,
although the mechanism remains unclear (Stimson and Vertino, 2002).
In human melanoma cells, ASC may play a dual role through diﬀer-
ential regulation of NF-κB. In metastatic melanoma, ASC promotes tu-
morigenesis, whereas in primary melanoma, ASC inhibits tumor growth
(Liu et al., 2013). Interestingly, this dual role of ASC is supported by
results in a mouse model of epithelial skin carcinogenesis where the
function of Asc is tissue-speciﬁc. In keratinocytes, Asc acted as a tumor-
suppressor, whereas in myeloid cells, it promoted tumorigenesis
(Drexler et al., 2012). Furthermore, ASC is down-regulated in human
primary epithelial skin cancers, but not in inﬂammatory proliferative
skin diseases. However, at the genetic level Da Silva et al. did not
conﬁrm an implication of NLRP3 in melanoma (Da Silva et al., 2016).
Recent work suggests that NLRP1 is the most important inﬂamma-
some sensor in human skin (Zhong et al., 2016; Uhlén et al., 2015), and
pathogenic germline NLRP1 mutations in two Mendelian monogenic
skin disorders, namely multiple self-healing palmoplantar carcinoma
and familial keratosis lichenoides chronica, are gain-of-function muta-
tions, leading to inﬂammasome activation (Zhong et al., 2016). The
authors showed that the mutations, which disrupt the PYD and LRR
folding domains, lead to constitutive NLRP1 self-oligomerization and
inﬂammasome activation. Surprisingly, the PYD domain of NLRP1,
unlike the PYDs from other NLRs, functions as an auto-inhibitory do-
main. Keratinocytes from those patients show spontaneous inﬂamma-
some activation and cytokine secretion, with IL1β being the most pre-
valent. Furthermore, using ex-vivo organotypic skin models, it was
shown that treatment with IL1α, IL1β and IL18 leads to epidermal
hyperplasias (Zhong et al., 2016).
5. Potential therapeutic approaches
Thymoquinone, a bioactive phytochemical constituent of Nigella
sativa seeds oil, has been shown to inhibit migration of human and
mouse melanoma cells in a mouse model of melanoma by targeting
NLRP3 inﬂammasome (Ahmad et al., 2013). Similarly, green tea
polyphenol epigallocatechin-3-gallate was shown to suppress mela-
noma growth by inhibiting NLRP1 inﬂammasome and IL1β-mediated
secretion (Ellis et al., 2011). Several biological agents are used suc-
cessfully today to block IL1 signaling in auto-inﬂammatory disorders
(Dinarello et al., 2012), which may also represent a potential ther-
apeutic option for targeting skin inﬂammation and preventing skin
tumorigenesis.
6. Conclusion
Skin is a dynamic organ maintaining homeostasis and providing
protection against environmental stimuli and pathogens. However,
these mechanisms can become overwhelmed over the time (aging) or
through constant stimulation (photoaging), resulting in irreversible
structural damage, chronic inﬂammation and carcinogenesis.
Inﬂammasomes play central roles in human pathophysiology,
regulating pro-inﬂammatory signals and host defense. Regulation of
their expression, assembly and activation has important implications in
the inﬂammatory process of skin diseases including cancer where cy-
tokines modulate cancer progression and invasiveness. Inﬂammasomes
may provide early biomarkers indicating photo-damage and beginning
of an inﬂammatory process in skin that require observation and su-
pervision. Thus targeting inﬂammasome(s) might be important to im-
prove skin inﬂammation, photoaging and the risk of tumorigenesis.
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